Researchers in the labs of QB3-Berkeley affiliates Jamie Cate and Alanna Schepartz engineered bacterial ribosomes to build non-canonical molecules—unlocking safer, cheaper routes to bioplastics and therapeutics.
Read the story: qb3.berkeley.edu/news/lifes-leg…
Read the story: qb3.berkeley.edu/news/lifes-leg…